Abstract

It has not been established how history of hypertension in the father or mother of pregnant women, combined with obesity or smoking, affects the risk of main forms of pregnancy-induced hypertension. A cohort of 912 pregnant women, recruited in the first trimester, was assessed; 113 (12.4%) women developed gestational hypertension (GH), 24 (2.6%) developed preeclampsia (PE) and 775 women remained normotensive (a control group). Multiple logistic regression was used to calculate adjusted odds ratios (AOR) (and 95% confidence intervals) of GH and PE for chronic hypertension in the father or mother of pregnant women. Some differences were discovered. (1) Paternal hypertension (vs. absence of hypertension in the family) was an independent risk factor for GH (AOR-a = 1.98 (1.2–3.28), p = 0.008). This odds ratio increased in pregnant women who smoked in the first trimester (AOR-a = 4.71 (1.01–21.96); p = 0.048) or smoked before pregnancy (AOR-a = 3.15 (1.16–8.54); p = 0.024), or had pre-pregnancy overweight (AOR-a = 2.67 (1.02–7.02); p = 0.046). (2) Maternal hypertension (vs. absence of hypertension in the family) was an independent risk factor for preeclampsia (PE) (AOR-a = 3.26 (1.3–8.16); p = 0.012). This odds ratio increased in the obese women (AOR-a = 6.51 (1.05–40.25); p = 0.044) and (paradoxically) in women who had never smoked (AOR-a = 5.31 (1.91–14.8); p = 0.001). Conclusions: Chronic hypertension in the father or mother affected the risk of preeclampsia and gestational hypertension in different ways. Modifiable factors (overweight/obesity and smoking) may exacerbate the relationships in question, however, paradoxically, beneficial effects of smoking for preeclampsia risk are also possible. Importantly, paternal and maternal hypertension were not independent risk factors for GH/PE in a subgroup of women with normal body mass index (BMI).

Highlights

  • Pregnancy-induced hypertension (PIH) is a serious public health problem [1]. This disease, which is characteristic of pregnancy, develops de novo after 20 weeks of gestation and includes gestational hypertension (GH) and preeclampsia (PE) as well as PE superimposed on chronic hypertension [2]

  • In the pregnancy-induced hypertension (PIH) group there were statistically significantly more women who developed gestational hypertension/preeclampsia (GH/PE) in the previous pregnancy (Prior GH/PE) (11.0% vs. 0.5%), as well as women whose mothers or sisters developed GH/PE (4.4% vs. 0.5%)

  • This study showed that chronic arterial hypertension in the parents of pregnant women affected the risk of preeclampsia (PE) and gestational hypertension (GH) in a different way

Read more

Summary

Introduction

Pregnancy-induced hypertension (PIH) is a serious public health problem [1]. This disease, which is characteristic of pregnancy, develops de novo after 20 weeks of gestation and includes gestational hypertension (GH) and preeclampsia (PE) as well as PE superimposed on chronic hypertension [2]. PIH affects an average of 10% of pregnant women, in some regions of the world this percentage is much higher [1,3,4]. Pregnancy-induced hypertension is a risk factor of cardiovascular disease and metabolic disorders later in life for both the mother and the child [2,3,6,7]. Qualification of pregnant women with increased supervision (before pregnancy, or at its beginning) can promote the health of the mother and baby

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call